Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catarina C Fernandes

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 2, 2010
Lateral mobility of nicotinic acetylcholine receptors on neurons is determined by receptor composition, local domain, and cell typeCatarina C Fernandes, Darwin K Berg, David Gómez-Varela
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 23, 2008
Postsynaptic action of brain-derived neurotrophic factor attenuates alpha7 nicotinic acetylcholine receptor-mediated responses in hippocampal interneuronsCatarina C Fernandes, António Pinto-Duarte, Joaquim Alexandre Ribeiro, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 2, 2010
Endogenous signaling through alpha7-containing nicotinic receptors promotes maturation and integration of adult-born neurons in the hippocampusNolan R Campbell, Catarina C Fernandes, Andrew W Halff, et al.
Acta Pharmacologica Sinica|May 13, 2009
Postsynaptic scaffolds for nicotinic receptors on neuronsRobert A Neff, David Gomez-Varela, Catarina C Fernandes, et al.
Biochemical Pharmacology|July 5, 2011
Nicotinic control of adult-born neuron fateNolan R Campbell, Catarina C Fernandes, Danielle John, et al.
Children (Basel, Switzerland)|March 6, 2021
Behavioral Inhibition in Childhood: European Portuguese Adaptation of an Observational Measure (Lab-TAB)Luís Faísca, Laura I Ferreira, Catarina C Fernandes, et al.
Advances in Therapy|January 12, 2024
Real-World Management of Patients with Pulmonary Arterial Hypertension: Insights from EXPOSUREAudrey Muller, Pilar Escribano-Subias, Catarina C Fernandes, et al.
Advances in Therapy|July 31, 2024
Four-Strata Risk Assessment in Patients with Pulmonary Arterial Hypertension Treated with Selexipag in Real-World Settings (EXPOSURE Study)Tobias J Lange, Pilar Escribano-Subias, Audrey Muller, et al.
Pulmonary Circulation|July 30, 2024
Selexipag in patients with pulmonary arterial hypertension associated with connective tissue disease (PAH-CTD): Real-world experience from EXPOSURESean Gaine, Pilar Escribano-Subias, Audrey Muller, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 16, 2025
Evaluating oral selexipag in pulmonary arterial hypertension: Insights on survival, safety, and dosing patterns from the complete observation period of GRIPHON and its open-label extensionVallerie V McLaughlin, Luke Howard, Jean Elwing, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 2, 2010
Lateral mobility of nicotinic acetylcholine receptors on neurons is determined by receptor composition, local domain, and cell typeCatarina C Fernandes, Darwin K Berg, David Gómez-Varela
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 23, 2008
Postsynaptic action of brain-derived neurotrophic factor attenuates alpha7 nicotinic acetylcholine receptor-mediated responses in hippocampal interneuronsCatarina C Fernandes, António Pinto-Duarte, Joaquim Alexandre Ribeiro, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 2, 2010
Endogenous signaling through alpha7-containing nicotinic receptors promotes maturation and integration of adult-born neurons in the hippocampusNolan R Campbell, Catarina C Fernandes, Andrew W Halff, et al.
Acta Pharmacologica Sinica|May 13, 2009
Postsynaptic scaffolds for nicotinic receptors on neuronsRobert A Neff, David Gomez-Varela, Catarina C Fernandes, et al.
Biochemical Pharmacology|July 5, 2011
Nicotinic control of adult-born neuron fateNolan R Campbell, Catarina C Fernandes, Danielle John, et al.
Children (Basel, Switzerland)|March 6, 2021
Behavioral Inhibition in Childhood: European Portuguese Adaptation of an Observational Measure (Lab-TAB)Luís Faísca, Laura I Ferreira, Catarina C Fernandes, et al.
Advances in Therapy|January 12, 2024
Real-World Management of Patients with Pulmonary Arterial Hypertension: Insights from EXPOSUREAudrey Muller, Pilar Escribano-Subias, Catarina C Fernandes, et al.
Advances in Therapy|July 31, 2024
Four-Strata Risk Assessment in Patients with Pulmonary Arterial Hypertension Treated with Selexipag in Real-World Settings (EXPOSURE Study)Tobias J Lange, Pilar Escribano-Subias, Audrey Muller, et al.
Pulmonary Circulation|July 30, 2024
Selexipag in patients with pulmonary arterial hypertension associated with connective tissue disease (PAH-CTD): Real-world experience from EXPOSURESean Gaine, Pilar Escribano-Subias, Audrey Muller, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 16, 2025
Evaluating oral selexipag in pulmonary arterial hypertension: Insights on survival, safety, and dosing patterns from the complete observation period of GRIPHON and its open-label extensionVallerie V McLaughlin, Luke Howard, Jean Elwing, et al.
Pageof 2